HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,614,941 | -6.9% | 11,218,033 | 0.0% | 98.94% | +0.7% |
| Q2 2023 | $394,762,581 | +7.8% | 11,218,033 | 0.0% | 98.29% | +1.9% |
| Q1 2023 | $366,268,777 | -40.7% | 11,218,033 | 0.0% | 96.46% | -1.1% |
| Q4 2022 | $618,113,619 | +24.4% | 11,218,033 | 0.0% | 97.50% | +2.1% |
| Q3 2022 | $496,847,000 | -9.2% | 11,218,033 | 0.0% | 95.45% | -1.1% |
| Q2 2022 | $547,104,000 | +0.2% | 11,218,033 | 0.0% | 96.54% | +16.0% |
| Q1 2022 | $545,757,000 | -99.9% | 11,218,033 | 0.0% | 83.25% | +9.3% |
| Q4 2021 | $478,337,000,000 | – | 11,218,033 | – | 76.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |